Answers are grounded in this paper and cite their sources.
Investigates plant extracts impacting tumor progression in prostate cancer, suggesting new therapeutic options.
Prostate cancer (PCa) is the second leading cause of cancer-related death among men in Brazil. Inflammation, oxidative stress, and sex hormones are known to play important roles in the initiation and progression of the disease, events that are also associated with the overexpression of members of the six-transmembrane epithelial antigen of the prostate (STEAP) family, particularly STEAP1, a protein with considerable potential as a therapeutic target. Among the factors associated with PCa etiology are genetic background, aging, ethnicity, and lifestyle, with dietary habits playing a particularly important role. In this context, plant-derived bioactive compounds have attracted increasing attention as chemopreventive strategies due to their ease of dietary intake, potential efficacy, and low toxicity toward healthy tissues. Indeed, jaboticaba peel extract (JPE) and araticum seed extract (ASE), both developed by our research group from Brazilian plant species, are rich in phytochemicals, and have demonstrated promising chemopreventive effects against PCa by promoting apoptosis and/or reducing the expression of oxidative stress- and inflammation-related markers, thereby slowing cancer progression in both in vitro and in vivo models, particularly under androgen-dependent conditions. In light of these findings, further investigation of the biological effects of these extracts is highly relevant, as they represent promising therapeutic alternatives that are cost-effective, readily applicable, and economically attractive, given that they are produced from plant by-products that would otherwise be discarded. Therefore, the overall aim of this project is to elucidate how these extracts interfere with cellular and molecular events associated with the progression of hormone-sensitive PCa, including epithelial–mesenchymal transition (EMT), inflammation, and oxidative stress, and to determine the extent to which these effects are associated with the hormone dependence of the disease through signaling pathways involving the androgen receptor and the STEAP1 protein.
No takes yet. Share an insight, caveat, or question.
Fábio Montico (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: